Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Vaccine
|
September 10, 2009
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection
James F Cummings, Michele D Spring, Robert J Schwenk, et al.
The Lancet. Infectious Diseases
|
April 17, 2015
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study
Michele D Spring, Jessica T Lin, Jessica E Manning, et al.
Plos One
|
April 25, 2009
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A
Michele D Spring, James F Cummings, Christian F Ockenhouse, et al.
Genome Medicine
|
January 10, 2020
Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential
Kara A Moser, Elliott F Drábek, Ankit Dwivedi, et al.
Plos Medicine
|
July 25, 2020
Correction: Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
Daniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Plos Medicine
|
May 15, 2020
Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
Daniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Plos Medicine
|
November 19, 2020
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
Mohammad S Hossain, Robert J Commons, Nicholas M Douglas, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Vaccine
|
September 10, 2009
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection
James F Cummings, Michele D Spring, Robert J Schwenk, et al.
The Lancet. Infectious Diseases
|
April 17, 2015
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study
Michele D Spring, Jessica T Lin, Jessica E Manning, et al.
Plos One
|
April 25, 2009
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A
Michele D Spring, James F Cummings, Christian F Ockenhouse, et al.
Genome Medicine
|
January 10, 2020
Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential
Kara A Moser, Elliott F Drábek, Ankit Dwivedi, et al.
Plos Medicine
|
July 25, 2020
Correction: Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
Daniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Plos Medicine
|
May 15, 2020
Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
Daniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Plos Medicine
|
November 19, 2020
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
Mohammad S Hossain, Robert J Commons, Nicholas M Douglas, et al.
Page
of 6